This model recapitulates the natural progression of human luminal B BC, which is hormone receptor–positive (estrogen receptor and/or progesterone receptor–positive) and either HER2 positive or negative and exhibits a less favorable prognosis compared with luminal A BC (Inic et al, 2014). The gene discussed is ERBB2; the disease is breast cancer.